OUR MISSION Icon Group’s mission is to deliver the best care possible, to as many people as possible, as close to home as possible. Through a comprehensive end-to-end model, Icon provides the full spectrum of cancer care including haematology, medical oncology, radiation oncology, chemotherapy compounding, pharmacy management and clinical research. Across the international network Icon saw over 2.5 million patient interactions in 2021 and is on target to move to four million annually by 2023. Icon Group is essential to the healthcare ecosystem and continues to innovate the way cancer care is delivered for the benefit of communities globally.
“ ICON GROUP IS ESSENTIAL TO THE HEALTHCARE ECOSYSTEM.” 10
ICON ANNUAL RESEARCH REPORT 2021
